Host: Horst Domdey, CEO, Bio^M Biotech Cluster Development

Welcome notes

Roland Weigert, State Secretary and Ulrike Wolf, Director General, Bavarian Ministry of Economic Affairs, Regional Development and Energy

Keynote:
Prerequisites for Future Medicine

Heyo Kroemer, Chief Executive Officer, Charité Berlin

Panel discussion:
The importance of basic research for the Medicine of the Future

Panelists:
Patrick Cramer, Director, Max Planck Institute for Multidisciplinary Sciences
Heyo Kroemer, Chief Executive Officer, Charité Berlin
André Schmidt, Medical Director Pharma, Novartis
Ernst-Ludwig Winnacker, Professor-Emeritus, LMU Munich

Moderation:
Ulrike Köhl, Director, Fraunhofer Institute for Cell Therapy and Immunology IZI

Session A (Room: Stadtsaal)

Innovative technologies: How could molecular advances shape the Medicine of the Future

Host: Hitto Kaufmann, CSO, Pieris Pharmaceuticals

Speakers:
mRNA platform as base for innovations
Gerald Wiegand, Country Director Germany, Moderna
André Schmidt, Medical Director Pharma, Novartis
Christian Itin, CEO, Autolus
Ulrike Köhl, Director, Fraunhofer Institute for Cell Therapy and Immunology IZI
Non-canonical CRISPR RNAs derived from host transcripts enable multiplexable RNA diagnostics
Cynthia Sharma, Chair Institute Molecular Infection Biology II, University of Würzburg

Session B (Room: Kleiner Saal)

Collecting and processing big data: Possibilities & Challenges

Host: Jens Wiehler, Managing Director DigiMed Bayern

Speakers/Panelists:
Anna Bauer-Mehren, Head Data Science, Roche Diagnostics
Benjamin Friedrich, CMO, Temedica
HTS for ion channels and other membrane proteins
Roland Geyer, COO, Lifespin
The future practice of medicine: more with less
Ralf Huss, Managing Director of the Institute of General Pathology and Molecular Diagnostics, University Hospital in Augsburg
Georg Münzenrieder, Head of Division, Bavarian State Ministry of Health and Care

Session C (Room: Säulensaal)

Nanotechnology and Biotech at the interface

Host: Ulrich Rant, CEO, Dynamic Biosensors

Speakers:
Virus traps and other biomedical machines of the future
Hendrik Dietz, Dept Physics TUM & Founder tilibit GmbH, capsitec GmbH, plectonic GmbH
Small Holes, Big Impact – Automated Electrophysiology in Drug Discovery
Niels Fertig, CEO, Nanion Technologies
New Depths in Sensing with Ultraprecise Nanostructures
Henriette Maaß, Managing Director, Nanostruct
Disruptive potential of nanopore technology for medical diagnostics – foresight by the BMBF Clusters4future finalist nanodiagBW
Felix von Stetten, Executive Board Member, Hahn-Schickard-Gesellschaft für angewandte Forschung

Host: Horst Domdey, CEO, Bio^M Biotech Cluster Development

Keynote lecture:
Insight must precede application: Max Planck and medicine

Patrick Cramer, Director, Max Planck Institute for Multidisciplinary Sciences

Wrap-up Day 1

Interlude:
The new CARMA-Fund

A new Investment Vehicle for Opportunities in Project and Startups. Established by Ascenion and Innovectis
Christian Stein, General Manager, Ascenion

Cabaret interlude (in German)

Christian Springer, Cabaret artist

Enjoy networking and a great evening reception!

Marina Belinska on her electric violine

Host:
Monika Jones, International TV and Conference Moderator

Keynote:
Covid-19 – lessons learned and future threats

Clemens Wendtner, Chief Medical Director, Infectiology, München Klinik

Panel discussion:
Looking Ahead - How can we prepare for future threats to our healthcare systems?

Panelists:
Thomas Gudermann, Dean of the Faculty of Medicine, LMU Munich
Elke Glasmacher, Lead Biomarker Discovery, Roche Diagnostics
Magdalena Kempa, Managing Director, smartbax
Clemens Wendtner, Chief Medical Director, Infectiology, München Klinik
Ulrike Wolf, Director General, Bavarian Ministry of Economic Affairs, Regional Development and Energy
Moderation:
Monika Jones, International TV and Conference Moderator

Session A: (Room: Stadtsaal)

The bavarian therapeutic strategy to combat the COVID 19 pandemic

Host:
Horst Domdey, CEO, Bio^M Biotech Cluster Development

Speakers:
Coviciclib - Therapeutic Brain Penetrating Antiviral Protein Kinase Inhibitor Programm
Michael Thormann, CEO & CSO, Origenis
Development of a Novel COVID-19 Replication Inhibitor
William Menzer, Eisbach Bio
ACE2-IgG fusion proteins as broad-spectrum virustraps that neutralize coronaviruses
Carsten Brockmeyer, CEO, Formycon
Inhalative Angiotensin 1-7 to substitute for Sars-CoV associated lack of ACE2 activity
Stefan Löffler, Explicat Pharma
Immuno-Modulation & mRNA-based Protein Replacement Therapy Programs for Treatment of Pulmonary Disease
Carsten Rudolph, CEO, ethris
Targeted microRNA therapeutics
Stefan Engelhardt, CSO, rnatics
PRS-220, a novel inhalable therapeutic intervention for IPF and post COVID fibrosis, targeting CTGF directly in the lung
Hitto Kaufmann, CSO, Pieris Pharmaceuticals

Session B: (Room: Kleiner Saal)

Impact of environment and way of living

Host:
Moritz Völker-Albert, Co-founder, EpiQMAx GmbH

Speakers:
Ageing and health from an epigenetic point of view
Ferdinand von Meyenn, Group Head Nutrition and Metabolic Epigenetics, ETH Zürich
Individualized training in a preventive setting: the iReAct study
Barbara Munz, Head of molecular and cell biological research lab, Department of Sports Medicine, Universität Tübingen
Routes to enhance stress resilience: Manipulation of genes or environment?
Mathias Schmidt, Head of Neurobiology of Stress Resilience lab, MPI of Psychiatry
Lara Maier, Senior Consultant, goetzpartners

Session C: (Room: Säulensaal)

Novel biochemical approaches for next generations of antibiotics

Host: Andreas Hauser, bayresq.net

Intro:
Novel RNA Antibiotics for Health and Disease
Franziska Faber, Project Lead, Rbiotics
Panelists:
Peter Hammann, Consultant Antibiotics & Natural Product Research
Michael Menden, Project Lead, DynamicKIT
Hannelore Meyer, Group Leader, MIH, TU München
Klaus Weinberger, Weinberger & Weinberger Life Sciences Consulting
Roman Wölfel, Director Institute for Microbiology, Universität der Bundeswehr

Wrap-up Sessions A-C
Poster award ceremony

Host:
Monika Jones, International TV and Conference Moderator

Keynote: From Excellence in Research to Breakthrough Solutions

Matthias H. Tschöp, CEO at Helmholtz Munich

The Livetalk-Series live from the on-site conference (in German)

Präzisionsmedizin:
Die Chancen der frühen Diagnose

Panelists:
Eva-Susanne Dietrich, Director, Institut für evidenzbasierte Positionierung im Gesundheitswesen, Universität Bonn
Hanns-Georg Klein, Medical Director,  MVZ Martinsried
Wolfgang Kern, Executive Management, MLL Münchner Leukämielabor
Matthias H. Tschöp, CEO, Helmholtz Munich

Moderation:
Jeanne Turczynski, Science Editor, Bayerischer Rundfunk

17:30

Beer & Brezn

18:30

End